Artrya (ASX:AYA) is set to raise AU$5 million via the placing of around 11.9 million shares at AU$0.42 apiece, according to a Tuesday filing with the Australian bourse.

Proceeds will support the commercialization of the company's Salix Coronary Anatomy platform for detecting coronary artery disease imaging markers, the filing said.

Petra Capital acted as sole lead manager and sole bookrunner to the placement.

Artrya's shares were down 6% in recent trade.